EUVIMEDEUVIMED entdecken
Crossref

Method Validation for the Determination of Nicotine and Nicotine Metabolite Levels in Urine, Serum, and Saliva Samples

Gülsüm Abuşoğlu iD, Duygu Eryavuz Onmaz, Ali Ünlü, Fatma Hümeyra Yerlikaya Aydemir, Sedat Abuşoğlu

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Gülsüm Abuşoğlu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Techniques, Vocational School of Health Sciences Medical Services and Techniques Institution, Selcuk University, Kon…. Hauptthemen laut MEDLINE: Nicotine, Saliva. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Selçuk University Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monitoring nicotine and its metabolites in bodily fluids is crucial for assessing tobacco exposure and related toxicity in clinical practice. Due to its high sensitivity for detecting low‐level analytes, liquid chromatography–tandem mass spectrometry (LC–MS/MS) was employed to enhance a robust and accurate analytical procedure for quantifying nicotine and its derivatives in serum, urine, and saliva. Comparative analysis was conducted on samples collected from individuals with and without smoking habits. The LC–MS/MS method utilized an API 3200 triple quadrupole instrument paired with a Phenomenex Luna C18 column. Method sensitivity was demonstrated through evaluation of sensitivity parameters, including LOD and LLOQ for each analyte in all matrices. Inter‐assay variability and bias values at the LLOQ level were kept below 20%. In serum, the LOD–LLOQ ranges were 0.02–0.05 μg/L for nicotine, 0.32–0.95 μg/L for cotinine, 0.07–0.25 μg/L for 3‐OH cotinine, and 0.22–0.69 μg/L for norcotinine. In urine, the respective values were 0.03–0.10, 0.23–0.82, 0.06–0.14, and 0.20–0.55 μg/L, and in saliva, the values were 0.12–1.59, 0.22–2.34, 0.10–0.17, and 0.33–3.01 μg/L. The proposed method is efficient, specific, and adaptable to routine clinical workflows, providing a valuable tool for monitoring tobacco‐related exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NicotineSalivaHumansTandem Mass SpectrometryReproducibility of ResultsLimit of DetectionChromatography, LiquidLinear ModelsCotinineMaleSmokingAdultFemale

Stichwörter der Autor:innen

LC MS/MScotininemethod validationnicotine

Substanzen

NicotineCotinine

Autor:innen und Institutionen

  • Department of Medical Laboratory Techniques, Vocational School of Health Sciences Medical Services and Techniques Institution, Selcuk University, Konya, Turkey.
  • Department of Biochemistry, Faculty of Medicine, Bandırma Onyedi Eylül University, Konya, Turkey.
  • Department of Biochemistry, Faculty of Medicine, Selcuk University, Konya, Turkey.

ORCID-Profile: Gülsüm Abuşoğlu

Förderung

  • Selçuk University Research Foundation

Zitieren

APA

Abuşoğlu, G., Onmaz, D. E., Ünlü, A., Aydemir, F. H. Y., & Abuşoğlu, S. (2025). Method Validation for the Determination of Nicotine and Nicotine Metabolite Levels in Urine, Serum, and Saliva Samples. Biomedical Chromatography. https://doi.org/10.1002/bmc.70096

Vancouver

Abuşoğlu G, Onmaz DE, Ünlü A, Aydemir FHY, Abuşoğlu S. Method Validation for the Determination of Nicotine and Nicotine Metabolite Levels in Urine, Serum, and Saliva Samples. Biomedical Chromatography. 2025. doi:10.1002/bmc.70096

BibTeX
@article{Abuolu2025,
  author = {Abuşoğlu, Gülsüm and Onmaz, Duygu Eryavuz and Ünlü, Ali and Aydemir, Fatma Hümeyra Yerlikaya and Abuşoğlu, Sedat},
  title = {Method Validation for the Determination of Nicotine and Nicotine Metabolite Levels in Urine, Serum, and Saliva Samples},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70096}
}
Kostenlos starten →